Current Issue cover

Dermalogica Expands Product Development Lab

Contact Author

Thank you for your inquiry. Please note that the author cannot provide individual medical advice. Also, if you have a customer service question, email customer service at

Fill out my online form.

Dermalogica has completed its new, expanded development, which is located at its global headquarters, and launched a new eye serum.

Dermalogica has announced the completion of its new, expanded development, located at its global headquarters in Carson, CA.

Previously: Dermalogica's PRO Cooling Contour Mask

Jane Wurwand, founder and chief visionary, CEO Aurelian Lis and Angela Murphy, Ph.D., vice president of technology innovation, welcomed the new network of staff and professional skin therapists to a ribbon cutting and innovation event to reveal the latest product, BioLumin-C Eye Serum, launch and lab facilities.

Continuing on its path of innovation, having created 17 products in 2019, Dermalogica needed to expand lab space to accommodate growth.

The new BioLumin-C Eye Serum, $70, launched January 2, 2020, is a supercharged Vitamin C eye serum that outsmarts visible premature skin aging caused by daily eye movements and environmental stress. Building on the success of Dermalogica’s BioLumin-C Serum, this lightweight serum for eyes delivers a highly-bioavailable Vitamin C complex to dramatically brighten and visibly firm the eye area.